# Amplify Energy Corp.: financial statements, quarterly

AMPY · NYSE · CIK 1533924 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ampy.md) · [Financials](/companies/ampy/financials.md) · [Filings](/companies/ampy/filings.md) · [Insiders](/companies/ampy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ampy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [76.8](/filings/0001558370-24-014637.md) | [79.0 d](/filings/0001558370-25-002273.md) | [76.3](/filings/0001558370-25-007383.md) | [79.5](/filings/0001558370-25-010536.md) | [69.9](/filings/0001104659-25-107056.md) | [69.0 d](/filings/0001104659-26-025299.md) | [72.1](/filings/0001104659-26-058661.md) | [68.4](/filings/0001104659-26-093408.md) | [66.4](/filings/0001104659-25-107056.md) | [56.6 d](/filings/0001104659-26-025299.md) | [37.5](/filings/0001104659-26-058661.md) | [52.7](/filings/0001104659-26-093408.md) |
| Cost of revenue | $m | [5.0](/filings/0001558370-24-014637.md) | [5.1 d](/filings/0001558370-25-002273.md) | [4.8](/filings/0001558370-25-007383.md) | [4.9](/filings/0001558370-25-010536.md) | [4.3](/filings/0001104659-25-107056.md) | [4.5 d](/filings/0001104659-26-025299.md) | [4.3](/filings/0001104659-26-058661.md) | [4.7](/filings/0001104659-26-093408.md) | [5.2](/filings/0001104659-25-107056.md) | [3.5 d](/filings/0001104659-26-025299.md) | [0.8](/filings/0001104659-26-058661.md) | [0.7](/filings/0001104659-26-093408.md) |
| Operating income | $m | [(12.3)](/filings/0001558370-24-014637.md) | [55.3 d](/filings/0001558370-25-002273.md) | [(9.1)](/filings/0001558370-25-007383.md) | [13.6](/filings/0001558370-25-010536.md) | [32.6](/filings/0001104659-25-107056.md) | [(6.7) d](/filings/0001104659-26-025299.md) | [(4.0)](/filings/0001104659-26-058661.md) | [12.6](/filings/0001104659-26-093408.md) | [(26.5)](/filings/0001104659-25-107056.md) | [94.9 d](/filings/0001104659-26-025299.md) | [(49.3)](/filings/0001104659-26-058661.md) | [23.2](/filings/0001104659-26-093408.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(13.4)](/filings/0001558370-24-014637.md) | [43.6 d](/filings/0001104659-25-036005.md) | [(9.4)](/filings/0001104659-25-107056.md) | [7.1](/filings/0001104659-25-107056.md) | [22.7](/filings/0001104659-25-107056.md) | [(7.4) d](/filings/0001104659-26-025299.md) | [(5.9)](/filings/0001104659-26-093408.md) | [6.4](/filings/0001104659-26-093408.md) | [(21.0)](/filings/0001104659-25-107056.md) | [64.4 d](/filings/0001104659-26-025299.md) | [(38.1)](/filings/0001104659-26-093408.md) | [17.3](/filings/0001104659-26-093408.md) |
| Diluted EPS | $ per share | [(0.34)](/filings/0001558370-24-014637.md) | not reported | [(0.24)](/filings/0001558370-25-007383.md) | [0.17](/filings/0001558370-25-010536.md) | [0.54](/filings/0001104659-25-107056.md) | not reported | [(0.15)](/filings/0001104659-26-058661.md) | [0.15](/filings/0001104659-26-093408.md) | [(0.52)](/filings/0001104659-25-107056.md) | not reported | [(0.93)](/filings/0001104659-26-058661.md) | [0.40](/filings/0001104659-26-093408.md) |
| Basic EPS | $ per share | [(0.34)](/filings/0001558370-24-014637.md) | not reported | [(0.24)](/filings/0001558370-25-007383.md) | [0.17](/filings/0001558370-25-010536.md) | [0.54](/filings/0001104659-25-107056.md) | not reported | [(0.15)](/filings/0001104659-26-058661.md) | [0.15](/filings/0001104659-26-093408.md) | [(0.52)](/filings/0001104659-25-107056.md) | not reported | [(0.93)](/filings/0001104659-26-058661.md) | [0.40](/filings/0001104659-26-093408.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.4](/filings/0001558370-23-017767.md) | [20.7](/filings/0001558370-25-002273.md) | [3.0](/filings/0001558370-24-007362.md) | [0.5](/filings/0001558370-24-011366.md) | not reported | [0.0](/filings/0001104659-25-107056.md) | not reported | [0.0](/filings/0001558370-25-010536.md) | [0.0](/filings/0001104659-25-107056.md) | [60.7](/filings/0001104659-26-093408.md) | [41.5](/filings/0001104659-26-058661.md) | [21.2](/filings/0001104659-26-093408.md) |
| Current assets | $m | [78.3](/filings/0001558370-23-017767.md) | [98.2](/filings/0001558370-25-002273.md) | [62.3](/filings/0001558370-24-007362.md) | [62.0](/filings/0001558370-24-011366.md) | [70.2](/filings/0001558370-24-014637.md) | [71.8](/filings/0001104659-26-025299.md) | [60.2](/filings/0001558370-25-007383.md) | [70.0](/filings/0001558370-25-010536.md) | [70.4](/filings/0001104659-25-107056.md) | [131](/filings/0001104659-26-093408.md) | [85.3](/filings/0001104659-26-058661.md) | [65.7](/filings/0001104659-26-093408.md) |
| Total assets | $m | [717](/filings/0001558370-23-017767.md) | [738](/filings/0001558370-25-002273.md) | [712](/filings/0001558370-24-007362.md) | [720](/filings/0001558370-24-011366.md) | [739](/filings/0001558370-24-014637.md) | [747](/filings/0001104659-26-025299.md) | [754](/filings/0001558370-25-007383.md) | [771](/filings/0001558370-25-010536.md) | [731](/filings/0001104659-25-107056.md) | [601](/filings/0001104659-26-093408.md) | [581](/filings/0001104659-26-058661.md) | [576](/filings/0001104659-26-093408.md) |
| Current liabilities | $m | [108](/filings/0001558370-23-017767.md) | [96.4](/filings/0001558370-25-002273.md) | [79.3](/filings/0001558370-24-007362.md) | [73.5](/filings/0001558370-24-011366.md) | [66.2](/filings/0001558370-24-014637.md) | [68.1](/filings/0001104659-26-025299.md) | [78.9](/filings/0001558370-25-007383.md) | [83.3](/filings/0001558370-25-010536.md) | [69.0](/filings/0001104659-25-107056.md) | [58.1](/filings/0001104659-26-093408.md) | [73.4](/filings/0001104659-26-058661.md) | [50.3](/filings/0001104659-26-093408.md) |
| Total liabilities | $m | [371](/filings/0001558370-23-017767.md) | [347](/filings/0001558370-25-002273.md) | [331](/filings/0001558370-24-007362.md) | [330](/filings/0001558370-24-011366.md) | [325](/filings/0001558370-24-014637.md) | [338](/filings/0001104659-26-025299.md) | [351](/filings/0001558370-25-007383.md) | [360](/filings/0001558370-25-010536.md) | [338](/filings/0001104659-25-107056.md) | [142](/filings/0001104659-26-093408.md) | [161](/filings/0001104659-26-058661.md) | [137](/filings/0001104659-26-093408.md) |
| Long-term debt | $m | [120](/filings/0001558370-23-017767.md) | [115](/filings/0001558370-25-002273.md) | [115](/filings/0001558370-24-007362.md) | [118](/filings/0001558370-24-011366.md) | [120](/filings/0001558370-24-014637.md) | [127](/filings/0001104659-26-025299.md) | [125](/filings/0001558370-25-007383.md) | [130](/filings/0001558370-25-010536.md) | [123](/filings/0001104659-25-107056.md) | [0.0](/filings/0001104659-26-025299.md) | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [346](/filings/0001558370-24-014637.md) | [391](/filings/0001104659-26-025299.md) | [381](/filings/0001104659-25-107056.md) | [390](/filings/0001104659-25-107056.md) | [415](/filings/0001104659-25-107056.md) | [409](/filings/0001104659-26-093408.md) | [403](/filings/0001104659-26-093408.md) | [411](/filings/0001104659-26-093408.md) | [393](/filings/0001104659-25-107056.md) | [459](/filings/0001104659-26-093408.md) | [421](/filings/0001104659-26-093408.md) | [439](/filings/0001104659-26-093408.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.0 d](/filings/0001558370-24-014637.md) | [28.4 d](/filings/0001558370-25-002273.md) | [7.7](/filings/0001558370-25-007383.md) | [15.4 d](/filings/0001558370-25-010536.md) | [15.7 d](/filings/0001104659-25-107056.md) | [12.5 d](/filings/0001104659-26-025299.md) | [25.5](/filings/0001104659-26-058661.md) | [23.7 d](/filings/0001104659-26-093408.md) | [13.4 d](/filings/0001104659-25-107056.md) | [(13.4) d](/filings/0001104659-26-025299.md) | [4.5](/filings/0001104659-26-058661.md) | [2.8 d](/filings/0001104659-26-093408.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [38.4](/filings/0001558370-23-017767.md) | [38.7](/filings/0001558370-24-007362.md) | [39.0](/filings/0001558370-24-011366.md) | [39.1](/filings/0001558370-24-014637.md) | [39.4](/filings/0001558370-25-007383.md) | [39.6](/filings/0001558370-25-010536.md) | [39.8](/filings/0001104659-25-107056.md) | [40.2](/filings/0001104659-26-058661.md) | [40.3](/filings/0001104659-26-093408.md) | [40.5](/filings/0001104659-25-107056.md) | [41.1](/filings/0001104659-26-058661.md) | [41.3](/filings/0001104659-26-093408.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 41,456,450 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093408.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.